A Long-Term Safety Follow-Up Study for Patients Treat With WU-CART-007

Clinical trial NCT05509855 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT05509855
Sponsor: Allotera Therapeutics
Status: ENROLLING_BY_INVITATION
Study type: OBSERVATIONAL

T-cell Acute Lymphoblastic Leukemia T-cell Lymphoblastic Lymphoma

Start date: 2022-08-22
Primary completion: 2037-07-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.